Question

Name a vaccine for poliomyelitis

Answer 1

BCG is the answer........

Answer 2

The Polio Vaccine is recommended in a 4-dose series in children at ages 2 months, 4 months, 6-18 months, and 4 through 6 years. The final dose in the series should be administered on or after the fourth birthday and at least 6 months after the previous dose.

Most U.S. adults are at low risk for polio exposure and are likely to have received polio immunizations. Therefore, routine immunization for adults 18 years or older is not recommended.  However, some U.S. adults are at increased risk for polio exposure.  Adults in any of the four groups listed below should be assessed for immunity and offered any additional doses:

Individuals traveling to countries where polio is endemic (Afghanistan, India, Pakistan and Nigeria) need to be immunized, or if previously immunized will generally need a one-time booster immunization. 

Health care personnel in close contact with patients shedding polio virus (unlikely in the United States).

Groups that do not vaccinate, and have had an outbreak of even a single case of polio, especially after traveling to endemic areas.

Lab workers handling specimens that may contain polioviruses (unlikely in the United States).

The polio vaccine should be given to pregnant/breastfeeding women who are at risk; the attack rate of polio is greater in pregnant versus non-pregnant women.

All current polio vaccines are trivalent, designed to protect against all three serotypes of poliovirus.  Two inactivated polio vaccines (IPV) are licensed in the United States, but only the IPOL (Sanofi Pasteur) is actually distributed.  IPV is given to adults in three doses on the following schedule:

Initial dose at anytime

Second dose 1-2 months later

Third dose 6-12 months following the second dose.